Treatment Information

Back

Lung Cancer treatment details. Chemotherapy.

St. James’s University Hospital, Leeds, United Kingdom.

Survival: monthsCountry:United Kingdom
Toxiciy Grade:4City/State/Province:Leeds
Treatments:ChemotherapyHospital:St. James’s University Hospital
Drugs:Journal:Link
Date:Apr 2011

Description:

Patients:
This study involved patients with previously treated non-small cell lung cancer who were divided into two separate treatment groups. Group A consisted of 25 patients with a median age of 63 years and 72% male. Group B had 25 patients with a median age of 60 years and 80% male.

Treatment:
Group A was treated with the chemotherapy agents docetaxel and oxaliplatin. Group B was treated with docetaxel only.

Toxicities:
Maximum toxicity grade was 4 for both treatment groups. In group A, grade 4 toxicities included neutropenia, febrile neutropenia, diarrhea, and fatigue. Group B reported the same toxicities as well as nausea and vomiting.

Results:
The reported median overall survival was 11.0 months for group A and 7.1 months for group B.

Support:
This study was partially supported by Sanofi-Aventis, the makers of oxaliplatin.

Correspondence: Dr. Ornella Belvedere; email: [email protected]



Back